Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Oligodendroglioma 2Central Nervous System Neoplasms 2Astrocytoma 2Urinary Bladder Neoplasms 1Urethral Neoplasms 1Spinal Cord Neoplasms 1Rhabdoid Tumor 1Optic Nerve Glioma 1Medulloblastoma 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Familial ependymoma 1Ependymoma 1Choroid Plexus Neoplasms 1Breast Neoplasms, Male 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Temozolomide 3Vincristine 2Radiotherapy 2Carboplatin 2lonafarnib 1etoposide phosphate 1emvododstat 1Valproic Acid 1Thiotepa 1Radiation 1Peripheral Blood Stem Cell Transplantation 1N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine 1Lomustine 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Drug Therapy 1Cyclophosphamide 1Cisplatin 1Chemotherapy, Adjuvant 13-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Spinal Cord Neoplasms × lonafarnib × Clear all
NCT00015899 2009-10-14

SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors

Pediatric Brain Tumor Consortium

Phase 1 Completed
53 enrolled
CNS

Familial ependymoma, Astrocytoma, Medulloblastoma, Oligodendroglioma, Spinal Cord Neoplasms, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Rhabdoid Tumor, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡